Form 4 for PCVX Vaxcyte, Inc.
Accepted 2022-09-21 00:00:00 ET · period of report 2022-09-19 · accession 0001209191-22-050941 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-09-21 | 2022-09-19 | PCVX | GUGGENHIME ANDREW | Pres, CFO | S - Sale+OE | $26.10 | -3,100 | 37.5K | -8% | -$80.9K |
| D | 2022-09-21 | 2022-09-19 | PCVX | GUGGENHIME ANDREW | Pres, CFO | M - OptEx | $5.35 | +3,100 | 40.6K | +8% | +$16.6K |
| D | 2022-09-21 | 2022-09-19 | PCVX | GUGGENHIME ANDREW | Pres, CFO | M - OptEx | $0.00 | -3,100 | 454.5K | -0.7% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-09-19 | S | D | 2,623 | $26.02 | 38,015 | D | — | — | (F2) The price reported is a weighted-average price. The shares were sold at prices ranging from $25.46 to $26.445. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 2 | Common | Common Stock | 2022-09-19 | M | A | 3,100 | $5.35 | 40,638 | D | — | — | |
| 3 | Common | Common Stock | 2022-09-19 | S | D | 477 | $26.52 | 37,538 | D | — | — | (F3) The price reported is a weighted-average price. The shares were sold at prices ranging from $26.465 to $26.56. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 4 | Derivative | Stock Option (right to buy) | 2022-09-19 | M | D | 3,100 | $0.00 | 454,518 | D | $5.35 · — to 2030-05-11 | 3,100 Common Stock | (F4) 1/4 of the shares subject to the option vested on May 1, 2021, and 1/48 of the shares vest monthly thereafter. |